| related words |
| heplisav |
| statistically |
| elvucitabine |
| intravitreal |
| ketotransdel |
| stimulation |
| influencers |
| kdl |
| trauma |
| santarus |
| pharmacogenetic |
| advair |
| outlicense |
| sseldorf |
| complimentary |
| aflibercept |
| valopicitabine |
| vlp |
| kaketsuken |
| rupture |
|
| related documents |
| 1157601--3/20/2008--SYNTA_PHARMACEUTICALS_CORP |
| 1157601--3/28/2007--SYNTA_PHARMACEUTICALS_CORP |
|
| related topics |
| {product, candidate, development} |
| {loss, insurance, financial} |
| {capital, credit, financial} |
| {provision, law, control} |
| {product, market, service} |
| {operation, international, foreign} |
| {loan, real, estate} |
| {stock, price, operating} |
| {condition, economic, financial} |
| {debt, indebtedness, cash} |
| {tax, income, asset} |
| {interest, director, officer} |
| {cost, operation, labor} |
| {competitive, industry, competition} |
| {control, financial, internal} |
| {regulation, government, change} |
| {stock, price, share} |
| {investment, property, distribution} |
| {operation, natural, condition} |
| {regulation, change, law} |
|